NAARDEN, The Netherlands--(BUSINESS WIRE)--BAC BV, the leading provider of antibody based affinity purification technology, has announced a collaboration with Bristol-Myers Squibb Company (NYSE:BMY) to generate CaptureSelect® affinity ligands for applications in the purification and analysis of a proprietary type of targeted biologic, called Adnectins™. Derived from human fibronectin, Adnectins are engineered using Bristol-Myers Squibb’s proprietary PROfusion™ technology to either block or stimulate the action of specific targets across a broad range of therapeutic areas.
The collaboration will focus on discovering and developing custom CaptureSelect® ligands for the routine purification of Adnectin biologics.
“Our CaptureSelect platform enables us to produce ligands that have high affinity and specificity for individual proteins and facilitates the generation of an exceptionally pure product in a single purification step,” commented Laurens Sierkstra, CEO of BAC. “We are delighted to collaborate with Bristol-Myers Squibb on the development of ligands for their Adnectin proteins. These custom ligands should simplify the purification process.”
—ENDS—
Notes to editors:
About BAC BV
BAC discovers, develops and manufactures affinity ligands and affinity purification products to support biopharmaceutical research and production. BAC’s CaptureSelect affinity purification and separation products are provided for the discovery, preclinical and clinical manufacturing of therapeutic proteins, including antibodies and antibody fragments. These products enable a reduced time to market, increased purity and yield and an overall lower cost of goods for biopharmaceutical drug development. BAC BV was established in 1995 as a Unilever subsidiary. Currently the Company employs 37 people with an R&D laboratory facility in Leiden and a state-of-the-art ISO 9001 certified manufacturing plant in Naarden, the Netherlands. For more information about BAC, visit our website at www.bacbv.com. For more information about CaptureSelect® products, visit our website at www.captureselect.com